Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

ABT-199 is a BH3 mimetic that selectively inhibits Bcl-2 with subnanomolar affinity (Ki < 0.010 nM), binding over 3 orders of magnitude less avidly to the related family proteins, Bcl-xL and Bcl-W (Kis = 48 and 245 nM, respectively).1 ABT-199 inhibits the growth of Bcl-2-dependent cell lines and in vivo tumor xenografts.1 This compound has shown antileukemic activity in patients with refractory chronic lymphocytic leukemia and holds promise to address additional Bcl-2-dependent cancers.1,2,2
WARNING This product is not for human or veterinary use.
1. ABT-
2. Bcl-